Last ¥634.00 JPY
Change Today -4.00 / -0.63%
Volume 279.0K
As of 1:00 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

lion corp (4912) Snapshot

Open
¥635.00
Previous Close
¥638.00
Day High
¥640.00
Day Low
¥632.00
52 Week High
12/4/14 - ¥675.00
52 Week Low
02/6/14 - ¥506.00
Market Cap
189.6B
Average Volume 10 Days
440.7K
EPS TTM
¥28.38
Shares Outstanding
299.1M
EX-Date
12/26/14
P/E TM
22.3x
Dividend
¥10.00
Dividend Yield
1.58%
Current Stock Chart for LION CORP (4912)

Related News

No related news articles were found.

lion corp (4912) Related Businessweek News

No Related Businessweek News Found

lion corp (4912) Details

Lion Corporation, together with its subsidiaries, manufactures and sells consumer and industrial products in Japan and internationally. It operates in four segments: Consumer Products, Industrial Products, Overseas, and Other. The company offers oral care products, such as toothpastes, toothbrushes, mouthwashes, interdental products, etc.; beauty care products comprising shampoos, conditioners and treatments, body washes, antiperspirants and deodorants, hair-nourishment treatments, etc.; fabric care products consisting of laundry detergents, fabric softeners, bleaches, anti-static agents, etc.; and living care products, including dishwashing detergents, household cleaners, cooking-aid products, etc. It also provides pharmaceutical products, such as analgesics, cold medicine, antidiarrheal drugs, digestive medicines, eyedrops, tonics and nutrients, insecticides, etc.; gift and channel-specific products, including novelties, gifts, functional food products (mail-order only), etc.; pet supplies consisting of sanitary products, functional pet food, body care and living care products, etc.; and dental products comprising toothpaste, toothbrushes, interdental products, dental chewing gum, supplements, pharmaceuticals, etc. In addition, the company manufactures and sells chemical products, such as chemical intermediate materials, including activators derived from oil and fats, electro-conductive carbon, detergents, and other items for institutional and other industrial uses, as well as provides surfactants and fatty acid nitrogen derivatives. Further, it is involved in the construction; management of real estate, including rental, dealing, and brokerage; transportation and storage; and other activities, as well as in the provision of human resources services. Lion Corporation was founded in 1891 and is headquartered in Tokyo, Japan.

6,162 Employees
Last Reported Date: 03/31/14
Founded in 1891

lion corp (4912) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

lion corp (4912) Key Developments

Lion Corporation to Release Excedrin LOX

Lion Corporation announced the release of Excedrin LOX, an orally administered painkiller formulated with the antipyretic analgesic ingredient loxoprofen sodium hydrate for the highly effective relief of back, shoulder and other body pain. Excedrin LOX will be available February 4, 2015 at pharmacies and drug stores nationwide. Product features: Formulated with loxoprofen sodium hydrate, an antipyretic analgesic ingredient that boasts superior effectiveness against body pain: This ingredient acts on the source of pain (peripheral nerves), thereby delivering highly effective pain relief, especially against back pain and pain due to stiff shoulders; Prodrug formula is easy on the stomach: Although some antipyretic analgesic ingredients tend to irritate the gastric mucosa, loxoprofen sodium hydrate is a prodrug, meaning that it retains a form that causes minimal irritation during the course of digestion and absorption. Since it is converted to an active antipyretic analgesic ingredient only after absorption, this ingredient is easy on the stomach; Effective with just one tablet per dosage: Small, easytoswallow 9mm tablets; Free of ingredients that cause drowsiness, such as hypnotic sedatives. Active Ingredients (per one tablet): Loxoprofen sodium hydrate: 68.1mg (60mg as anhydride); Efficacy: Relief from back pain, pain due to stiff shoulders, headache, arthralgia, neuralgia, muscle pain, pain from bone fractures, sprains or bruises, menstrual pain, toothache, pain after tooth extraction, sore throat, earache, pain from trauma; Antipyretic effect for relief from chills or fever. Directions for Use and Dosage: Adults (15 years and older): take one tablet up to twice per day upon the development of symptoms. A third dosage is permissible if symptoms recur. Avoid taking on an empty stomach and wait at least four hours before taking again. Take with cold or warm water. Precautions: Receive instructions from a pharmacist and carefully read the attached warnings before use. Ask a healthcare professional before use if having drug or other allergies.

Lion Corporation Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Year Ending December 31, 2014

Lion Corporation reported consolidated earnings results for the nine months ended September 30, 2014. For the nine months, the company reported net sales of JPY 265,305 million against JPY 252,222 million a year ago. Operating income was JPY 7,343 million against JPY 5,643 million a year ago. Ordinary income was JPY 8,202 million against JPY 6,717 million a year ago. Net income was JPY 4,895 million against JPY 3,377 million a year ago. Diluted EPS was JPY 17.52 against JPY 12.56 a year ago. Income before income taxes was JPY 8,515 million against JPY 6,989 million a year ago. Income before minority interests was JPY 5,330 million against JPY 3,967 million a year ago. For the fiscal year ending December 31, 2014, the company expects net sales of JPY 360,000 million, operating income of JPY 12,000 million, ordinary income of JPY 13,000 million, net income of JPY 7,000 million and EPS of JPY 26.10.

Lion Corporation Presents at 9th Annual Daiwa Investment Conference, Nov-18-2014

Lion Corporation Presents at 9th Annual Daiwa Investment Conference, Nov-18-2014 . Venue: Island Shangri-La, Pacific Place, Supreme Court Road, Admiralty, Hong Kong, Hong Kong.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4912:JP ¥634.00 JPY -4.00

4912 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4912.
View Industry Companies
 

Industry Analysis

4912

Industry Average

Valuation 4912 Industry Range
Price/Earnings 21.7x
Price/Sales 0.4x
Price/Book 1.3x
Price/Cash Flow 14.2x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LION CORP, please visit www.lion.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.